656 related articles for article (PubMed ID: 31696388)
1. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
[TBL] [Abstract][Full Text] [Related]
2. ADC at 3.0 T as a noninvasive biomarker for preoperative prediction of Ki67 expression in invasive ductal carcinoma of breast.
Shen L; Zhou G; Tong T; Tang F; Lin Y; Zhou J; Wang Y; Zong G; Zhang L
Clin Imaging; 2018; 52():16-22. PubMed ID: 29501957
[TBL] [Abstract][Full Text] [Related]
3. An MRI-based Radiomics Classifier for Preoperative Prediction of Ki-67 Status in Breast Cancer.
Liang C; Cheng Z; Huang Y; He L; Chen X; Ma Z; Huang X; Liang C; Liu Z
Acad Radiol; 2018 Sep; 25(9):1111-1117. PubMed ID: 29428211
[TBL] [Abstract][Full Text] [Related]
4. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
[No Abstract] [Full Text] [Related]
5. Breast cancer Ki67 expression prediction by DCE-MRI radiomics features.
Ma W; Ji Y; Qi L; Guo X; Jian X; Liu P
Clin Radiol; 2018 Oct; 73(10):909.e1-909.e5. PubMed ID: 29970244
[TBL] [Abstract][Full Text] [Related]
6. Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
Kim EJ; Kim SH; Park GE; Kang BJ; Song BJ; Kim YJ; Lee D; Ahn H; Kim I; Son YH; Grimm R
J Magn Reson Imaging; 2015 Dec; 42(6):1666-78. PubMed ID: 25919239
[TBL] [Abstract][Full Text] [Related]
7. Utility of apparent diffusion coefficient as an imaging biomarker for assessing the proliferative potential of invasive ductal breast cancer.
Zhuang Z; Zhang Q; Zhang D; Cheng F; Suo S; Geng X; Hua J; Xu J
Clin Radiol; 2018 May; 73(5):473-478. PubMed ID: 29273228
[TBL] [Abstract][Full Text] [Related]
8. [Value of radiomics models based on MRI diffusion weighted imaging and apparent diffusion coefficient in differentiating benign and malignant thyroid nodules].
Xu HJ; Yang Q; He P; Luo HH; Deng WM; Liu Z; Luo DH
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3279-3286. PubMed ID: 37926572
[No Abstract] [Full Text] [Related]
9. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
10. Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors.
Wang H; Hu D; Yao H; Chen M; Li S; Chen H; Luo J; Feng Y; Guo Y
Eur Radiol; 2019 Nov; 29(11):6182-6190. PubMed ID: 31016445
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the HER-2 status of breast cancer using mammography radiomics features.
Zhou J; Tan H; Bai Y; Li J; Lu Q; Chen R; Zhang M; Feng Q; Wang M
Eur J Radiol; 2019 Dec; 121():108718. PubMed ID: 31711023
[TBL] [Abstract][Full Text] [Related]
12. Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer.
Feng S; Yin J
Front Oncol; 2022; 12():847880. PubMed ID: 36895526
[TBL] [Abstract][Full Text] [Related]
13. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
14. Apparent diffusion coefficient on 3.0 Tesla magnetic resonance imaging and prognostic factors in breast cancer.
De Felice C; Cipolla V; Guerrieri D; Santucci D; Musella A; Porfiri LM; Meggiorini ML
Eur J Gynaecol Oncol; 2014; 35(4):408-14. PubMed ID: 25118482
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
16. Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer.
Shin HJ; Kim SH; Lee HJ; Gong G; Baek S; Chae EY; Choi WJ; Cha JH; Kim HH
NMR Biomed; 2016 Aug; 29(8):1070-8. PubMed ID: 27332719
[TBL] [Abstract][Full Text] [Related]
17. Soft Tissue Sarcomas: Preoperative Predictive Histopathological Grading Based on Radiomics of MRI.
Zhang Y; Zhu Y; Shi X; Tao J; Cui J; Dai Y; Zheng M; Wang S
Acad Radiol; 2019 Sep; 26(9):1262-1268. PubMed ID: 30377057
[TBL] [Abstract][Full Text] [Related]
18. Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
Kim SY; Kim EK; Moon HJ; Yoon JH; Koo JS; Kim SG; Kim MJ
Magn Reson Imaging; 2018 Dec; 54():176-182. PubMed ID: 30172938
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
Shin JK; Kim JY
J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
